Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-02-24
2011-12-20
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S393000
Reexamination Certificate
active
08080560
ABSTRACT:
Pharmaceutical formulations and methods including an immune response modifier (IRM) compound and an oleic acid component are provided where stability is improved by using oleic acid have low polar impurities such as peroxides.
REFERENCES:
patent: 24906 (1960-12-01), Ulrich
patent: 3700674 (1972-10-01), Diehl et al.
patent: 4013665 (1977-03-01), Crenshaw et al.
patent: 4052393 (1977-10-01), Treuner
patent: 4191767 (1980-03-01), Warner, Jr. et al.
patent: 4197403 (1980-04-01), Warner, Jr. et al.
patent: 4411893 (1983-10-01), Johnson et al.
patent: 4601856 (1986-07-01), Suzuki et al.
patent: 4686125 (1987-08-01), Johnston et al.
patent: 4689338 (1987-08-01), Gerster
patent: 4695465 (1987-09-01), Kigasawa et al.
patent: 4698348 (1987-10-01), Gerster
patent: 4722941 (1988-02-01), Eckert et al.
patent: 4746515 (1988-05-01), Cheng et al.
patent: 4751087 (1988-06-01), Wick
patent: 4863970 (1989-09-01), Patel et al.
patent: 4908389 (1990-03-01), Mahjour et al.
patent: 4929624 (1990-05-01), Gerster
patent: 5008110 (1991-04-01), Benecke et al.
patent: 5238944 (1993-08-01), Wick et al.
patent: 5266575 (1993-11-01), Gerster
patent: 5268376 (1993-12-01), Gester
patent: 5300291 (1994-04-01), Sablotsky et al.
patent: 5346905 (1994-09-01), Gerster
patent: 5352784 (1994-10-01), Nikolaides et al.
patent: 5389640 (1995-02-01), Gerster et al.
patent: 5446153 (1995-08-01), Lindstrom et al.
patent: 5472982 (1995-12-01), Suzuki
patent: 5482936 (1996-01-01), Lindstrom
patent: 5532030 (1996-07-01), Hirose et al.
patent: 5736553 (1998-04-01), Wick et al.
patent: 5756747 (1998-05-01), Gerster et al.
patent: 5919815 (1999-07-01), Bradley et al.
patent: 5939090 (1999-08-01), Beaurline et al.
patent: 6039969 (2000-03-01), Tomai et al.
patent: 6103697 (2000-08-01), Bergstrand et al.
patent: 6110929 (2000-08-01), Gerster et al.
patent: 6194425 (2001-02-01), Gerster et al.
patent: 6200592 (2001-03-01), Tomai et al.
patent: 6210712 (2001-04-01), Edgren et al.
patent: 6245776 (2001-06-01), Skwierczynski et al.
patent: 6267957 (2001-07-01), Green et al.
patent: 6331539 (2001-12-01), Crooks et al.
patent: 6376669 (2002-04-01), Rice et al.
patent: 6425776 (2002-07-01), Fredl
patent: 6451810 (2002-09-01), Coleman et al.
patent: 6498261 (2002-12-01), Ewbank et al.
patent: 6525064 (2003-02-01), Dellaria et al.
patent: 6541485 (2003-04-01), Crooks et al.
patent: 6545016 (2003-04-01), Dellaria et al.
patent: 6545017 (2003-04-01), Dellaria et al.
patent: 6559182 (2003-05-01), Purcell
patent: 6562363 (2003-05-01), Mantelle et al.
patent: 6573273 (2003-06-01), Crooks et al.
patent: 6638528 (2003-10-01), Kanios
patent: 6656938 (2003-12-01), Crooks et al.
patent: 6660735 (2003-12-01), Crooks et al.
patent: 6660747 (2003-12-01), Crooks et al.
patent: 6664260 (2003-12-01), Charles et al.
patent: 6664264 (2003-12-01), Dellaria et al.
patent: 6664265 (2003-12-01), Crooks et al.
patent: 6667312 (2003-12-01), Bonk et al.
patent: 6670372 (2003-12-01), Charles et al.
patent: 6677347 (2004-01-01), Crooks et al.
patent: 6677348 (2004-01-01), Heppner et al.
patent: 6677349 (2004-01-01), Griesgraber
patent: 6683088 (2004-01-01), Crooks et al.
patent: 6756382 (2004-06-01), Coleman et al.
patent: 6797718 (2004-09-01), Dellaria et al.
patent: 6803420 (2004-10-01), Cleary et al.
patent: 6818650 (2004-11-01), Griesgraber
patent: 7056528 (2006-06-01), Bracht et al.
patent: 7504114 (2009-03-01), Kurita et al.
patent: 2002/0128345 (2002-09-01), Paul
patent: 2003/0026794 (2003-02-01), Fein
patent: 2003/0059471 (2003-03-01), Compton et al.
patent: 2003/0072814 (2003-04-01), Maibach et al.
patent: 2003/0096012 (2003-05-01), Besse et al.
patent: 2003/0124191 (2003-07-01), Besse et al.
patent: 2003/0170308 (2003-09-01), Cleary et al.
patent: 2003/0199538 (2003-10-01), Skwierczynski
patent: 2003/0211163 (2003-11-01), Chong
patent: 2004/0089855 (2004-05-01), Oommen et al.
patent: 2004/0091491 (2004-05-01), Kedl et al.
patent: 2004/0132766 (2004-07-01), Griesgraber
patent: 2004/0147543 (2004-07-01), Hays et al.
patent: 2004/0176367 (2004-09-01), Griesgraber et al.
patent: 2004/0192585 (2004-09-01), Owens et al.
patent: 2004/0242770 (2004-12-01), Feldstein et al.
patent: 2005/0037030 (2005-02-01), Kumar et al.
patent: 2005/0175630 (2005-08-01), Raz et al.
patent: 2005/0201959 (2005-09-01), David
patent: 2005/0276842 (2005-12-01), Zhang et al.
patent: 2005/0281772 (2005-12-01), Bromley et al.
patent: 2006/0024243 (2006-02-01), Arkin et al.
patent: 2006/0034779 (2006-02-01), Arkin et al.
patent: 2006/0039931 (2006-02-01), Scheiwe et al.
patent: 2007/0167479 (2007-07-01), Busch et al.
patent: 2007/0196457 (2007-08-01), Zhang et al.
patent: 0 107 455 (1986-07-01), None
patent: 0 187 705 (1986-07-01), None
patent: 0 394 026 (1993-09-01), None
patent: 0 582 581 (1994-02-01), None
patent: 1 512 685 (2005-03-01), None
patent: P0002103 (2000-10-01), None
patent: 61-00297 (1986-01-01), None
patent: 62-148449 (1987-07-01), None
patent: 05-246948 (1993-09-01), None
patent: 07-138145 (1995-05-01), None
patent: 76045 (1985-12-01), None
patent: 76145 (1985-12-01), None
patent: 76145 (1985-12-01), None
patent: 88/09676 (1988-12-01), None
patent: WO-88/09676 (1988-12-01), None
patent: WO-92/15582 (1992-09-01), None
patent: WO-01/06829 (2001-02-01), None
patent: WO-01/07009 (2001-02-01), None
patent: WO-2004/024126 (2004-03-01), None
patent: WO-2004/037201 (2004-05-01), None
patent: WO 2005/020995 (2005-03-01), None
patent: WO-2005/020999 (2005-03-01), None
patent: WO-2005/067897 (2005-07-01), None
patent: WO-2005/074894 (2005-08-01), None
patent: WO-2005/079143 (2005-09-01), None
patent: WO 2005/089317 (2005-09-01), None
patent: WO-2006/074046 (2006-07-01), None
patent: WO-2006/074046 (2006-07-01), None
patent: WO-2008/010963 (2008-01-01), None
patent: WO-2008/010963 (2008-01-01), None
Croda, Inc. Product Literature, “SUPER REFINED® OLEIC ACID NF”Pharmaceutical&Nutritional, PN-38, (2002), pp. 1-4. (Croda, Inc.: Parisippany, NY).
Naik et al., “Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans,”Journal of Controlled Release37 (1995) pp. 299-306.
Green et al., “In vitro and in vivo enhancement of skin permeation with oleic and lauric acids,”International Journal of Pharmaceutics, 48 (1988), pp. 103-111.
Yamashita et al., “Analysis of in vivo skin penetration enhancement by oleic acid based on a two-layer diffusion model with polar and nonpolar routes in the stratum corneum,”International Journal of Pharmaceutics117 (1995), pp. 173-179.
Yamane et al., “Effects of terpenes and oleic acid as skin penetration enhancers towards 5-fluorouracil as assessed with time; permeation, partitioning and differential scanning calorimetry,”International Journal of Pharmaceutics116, (1995), pp. 237-251.
Meshulam et al., “Transdermal Penetration of Physostigmine: Effects of Oleic Acid Enhancer,”Drug Development Research28 (1993), pp. 510-515.
Kim et al., “Enhanced Bioavilability of Aceclofenac Using Solid Dispersions: Bioequivalence Test of Capsule and Tablet with Different Doses in Human Volunteers,”Controlled Release Society 29th Annual Meeting Proceedings, (2002), pp. 730-731.
MacGregor et al., “Influence of lipolysis on drug absorption from the gastro-intestinal tract,”Advanced Drug Delivery Reviews25 (1997), pp. 33-46.
N. Thorgaard Pedersen, “Fat Digestion Tests,”Digestion37:suppl. 1 (1987), pp. 25-34.
Bonte et al., “Experimental Myocardial Imaging with I-Labeled Oleic Acid,”Work in Progress, Radiology108: (1973), pp. 195-196.
Abbasi et al., “Base Induced Cyclization of Some Quinolines. Formation of Fused Nitrogen Heterocyclic Ring System”Monatshefte für Chemie(1980)111:963-969.
Abbasi et al., “Base Induced Cyclization of Some Quinolines. Formation of Fused Nitrogen Hetercyclic Ring System,”Chemical Abstracts(1981) 94:47216.
Bachman, et al., “Synthesis of Substituted Quinolylamines. Derivatives of 4-Amino-7-Chloroquinoline,”Journal of Organic Chemistry, 15(1950),
Nelson Robert J.
Statham Alexis S.
3M Innovative Properties Company
Claytor Renee
Daley, Jr. William J.
Edwards Wildman Palmer LLP
Manso Peter J.
LandOfFree
Immune response modifier formulations containing oleic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immune response modifier formulations containing oleic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immune response modifier formulations containing oleic acid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4313719